Marrium Z. Qureshi, PharmD

Articles by Marrium Z. Qureshi, PharmD

FDA

FDA Approves Belumosudil (Rezurock) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD)

ByMarrium Z. Qureshi, PharmD,Kevin W. Chamberlin, PharmD

October 27th 2021

Latest Updated Articles

Trending on Drug Topics

FDA Adds NAION Eye Risk Warning to All GLP-1 Labels

The Pharmacy Model Creating New Billing Pathways, Improved Recognition

New Report Finds Pharmacies Key in Long-Term GLP-1 Success

Vaxcyte’s VAX-31 Pneumococcal Vaccine Meets All Phase 3 Primary Goals

Doxycycline Use Associated with Higher Risk of Pregnancy Loss